OpenURL Connection Search

Select item for more details and to access through your institution.

Comparing the rate of immunotherapy treatment change due to toxicity by sex.
Published in:
Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1932
By:
- Chua, Kevin J.;
- Kronstedt, Shane;
- Kaldany, Alain;
- Srivastava, Arnav;
- Doppalapudi, Sai Krishnaraya;
- Liu, Hao;
- Tarhini, Ahmad A.;
- Gatti‐Mays, Margaret;
- Gaughan, Elizabeth;
- Hu‐Lieskovan, Siwen;
- Aljumaily, Raid;
- Nepple, Kenneth;
- Schneider, Bryan;
- Sterling, Joshua;
- Singer, Eric A.
Publication type:
Article
Neoadjuvant chemotherapy in the setting of locally advanced olfactory neuroblastoma with intracranial extension.
Published in:
2011
By:
- Aljumaily, Raid M.;
- Nystrom, John S.;
- Wein, Richard O.
Publication type:
Case Study
Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study.
Published in:
Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 762, doi. 10.1177/1078155218771152
By:
- Mukherjee, Sarbajit;
- Ibrahimi, Sami;
- Khalid, Bilal;
- Roman, Darwin;
- Zhao, Daniel;
- Aljumaily, Raid
Publication type:
Article
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
Published in:
Investigational New Drugs, 2021, v. 39, n. 1, p. 182, doi. 10.1007/s10637-020-01000-6
By:
- Hecht, J. Randolph;
- Papadopoulos, Kyriakos P.;
- Falchook, Gerald S.;
- Patel, Manish R.;
- Infante, Jeffrey R.;
- Aljumaily, Raid;
- Wong, Deborah J.;
- Autio, Karen A.;
- Wainberg, Zev A.;
- Bauer, Todd M.;
- Javle, Milind;
- Pant, Shubham;
- Bendell, Johanna;
- Hung, Annie;
- Ratti, Navneet;
- VanVlasselaer, Peter;
- Verma, Rakesh;
- Leveque, Joseph;
- Rao, Sujata;
- Oft, Martin
Publication type:
Article
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors.
Published in:
Investigational New Drugs, 2019, v. 37, n. 3, p. 461, doi. 10.1007/s10637-018-0665-y
By:
- Jimeno, Antonio;
- Moore, Kathleen N.;
- Gordon, Michael;
- Chugh, Rashmi;
- Diamond, Jennifer R.;
- Aljumaily, Raid;
- Mendelson, David;
- Kapoun, Ann M.;
- Xu, Lu;
- Stagg, Robert;
- Smith, David C.
Publication type:
Article
Optimal Management of Bone Metastases in Prostate Cancer.
Published in:
Current Oncology Reports, 2011, v. 13, n. 3, p. 222, doi. 10.1007/s11912-011-0160-5
By:
- Aljumaily, Raid;
- Mathew, Paul
Publication type:
Article
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03654-0
By:
- Patel, Manish R.;
- Johnson, Melissa;
- Winer, Ira;
- Arkenau, Hendrik-Tobias;
- Cook, Natalie;
- Samouëlian, Vanessa;
- Aljumaily, Raid;
- Kitano, Shigehisa;
- Duffy, Christine;
- Ge, Miaomiao;
- Elgadi, Mabrouk;
- Siu, Lillian L.
Publication type:
Article
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 689, doi. 10.1007/s00280-021-04239-9
By:
- Li, Chao;
- Hart, Lowell;
- Owonikoko, Taofeek K.;
- Aljumaily, Raid;
- Rocha Lima, Caio Max;
- Conkling, Paul R.;
- Webb, Roy Timothy;
- Jotte, Robert M.;
- Schuster, Steven;
- Edenfield, William J.;
- Smith, Deborah A.;
- Sale, Mark;
- Roberts, Patrick J.;
- Malik, Rajesh K.;
- Sorrentino, Jessica A.
Publication type:
Article
Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.
Published in:
International Journal of Cancer, 2021, v. 149, n. 2, p. 403, doi. 10.1002/ijc.33556
By:
- Tannir, Nizar M.;
- Papadopoulos, Kyriakos P.;
- Wong, Deborah J.;
- Aljumaily, Raid;
- Hung, Annie;
- Afable, Manuel;
- Kim, Jong Seok;
- Ferry, David;
- Drakaki, Alexandra;
- Bendell, Johanna;
- Naing, Aung
Publication type:
Article
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer.
Published in:
Targeted Oncology, 2021, v. 16, n. 5, p. 569, doi. 10.1007/s11523-021-00835-0
By:
- Moore, Kathleen N.;
- Hong, David S.;
- Patel, Manish R.;
- Pant, Shubham;
- Ulahannan, Susanna V.;
- Jones, Suzanne;
- Meric-Bernstam, Funda;
- Wang, Judy S.;
- Aljumaily, Raid;
- Hamilton, Erika P.;
- Wittchen, Erika S.;
- Wang, Xuejing;
- Lin, Aimee Bence;
- Bendell, Johanna C.
Publication type:
Article
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.
Published in:
Oncologist, 2023, v. 28, n. 7, p. 640, doi. 10.1093/oncolo/oyad029
By:
- Johnson, Melissa L;
- Patel, Manish R;
- Aljumaily, Raid;
- Jones, Suzanne F;
- Burris, Howard A;
- Spigel, David R
Publication type:
Article
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Published in:
2021
By:
- Hart, Lowell L.;
- Ferrarotto, Renata;
- Andric, Zoran G.;
- Beck, J. Thaddeus;
- Subramanian, Janakiraman;
- Radosavljevic, Davorin Z.;
- Zaric, Bojan;
- Hanna, Wahid T.;
- Aljumaily, Raid;
- Owonikoko, Taofeek K.;
- Verhoeven, Didier;
- Xiao, Jie;
- Morris, Shannon R.;
- Antal, Joyce M.;
- Hussein, Maen A.
Publication type:
journal article

Found: 12